Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease

J Dermatol. 2022 Jul;49(7):e221-e223. doi: 10.1111/1346-8138.16341. Epub 2022 Mar 3.

Authors

Affiliations

¹ Department of Dermatology, Showa University School of Medicine, Tokyo, Japan.
² Department of Hygiene, Kawasaki Medical Univerity, Kurashiki, Japan.
³ Department of Dermatology, Showa University Fujigaoka Hospital, Yokohama, Japan.
⁴ Department of Dermatology, Showa University Koto Toyosu Hospital, Tokyo, Japan.
⁵ Department of of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo, Japan.

PMID: 35243680
DOI: 10.1111/1346-8138.16341

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Autoimmune Diseases*
Biomarkers
Drug Hypersensitivity Syndrome* / diagnosis
Drug Hypersensitivity Syndrome* / etiology
Eosinophilia* / chemically induced
Eosinophilia* / diagnosis
Humans
Mass Screening

Substances

Biomarkers